[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Neuroprotection Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application

January 2022 | 90 pages | ID: NEA2E94F5C90EN
Prof Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report describes the global market size of Neuroprotection from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027.

For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Neuroprotection as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share

Applications Segment:
Prevention
Treatment

Companies Covered:
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
etc.

Please ask for sample pages for full companies list

Base Year: 2022
Historical Data: from 2017 to 2021
Forecast Data: from 2022 to 2027

Any special requirements about this report, please let us know and we can provide custom report.
CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Neuroprotection Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST NEUROPROTECTION MARKET IN NORTH AMERICA (2017-2027)

8.1 Neuroprotection Market Size
8.2 Neuroprotection Market by End Use
8.3 Competition by Players/Suppliers
8.4 Neuroprotection Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST NEUROPROTECTION MARKET IN SOUTH AMERICA (2017-2027)

9.1 Neuroprotection Market Size
9.2 Neuroprotection Market by End Use
9.3 Competition by Players/Suppliers
9.4 Neuroprotection Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST NEUROPROTECTION MARKET IN ASIA & PACIFIC (2017-2027)

10.1 Neuroprotection Market Size
10.2 Neuroprotection Market by End Use
10.3 Competition by Players/Suppliers
10.4 Neuroprotection Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST NEUROPROTECTION MARKET IN EUROPE (2017-2027)

11.1 Neuroprotection Market Size
11.2 Neuroprotection Market by End Use
11.3 Competition by Players/Suppliers
11.4 Neuroprotection Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST NEUROPROTECTION MARKET IN MEA (2017-2027)

12.1 Neuroprotection Market Size
12.2 Neuroprotection Market by End Use
12.3 Competition by Players/Suppliers
12.4 Neuroprotection Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL NEUROPROTECTION MARKET (2017-2022)

13.1 Neuroprotection Market Size
13.2 Neuroprotection Market by End Use
13.3 Competition by Players/Suppliers
13.4 Neuroprotection Market Size by Type

CHAPTER 14 GLOBAL NEUROPROTECTION MARKET FORECAST (2022-2027)

14.1 Neuroprotection Market Size Forecast
14.2 Neuroprotection Application Forecast
14.3 Competition by Players/Suppliers
14.4 Neuroprotection Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Daiichi Sankyo Company
  15.1.1 Company Profile
  15.1.2 Main Business and Neuroprotection Information
  15.1.3 SWOT Analysis of Daiichi Sankyo Company
  15.1.4 Daiichi Sankyo Company Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.2 Eli Lilly and Company
  15.2.1 Company Profile
  15.2.2 Main Business and Neuroprotection Information
  15.2.3 SWOT Analysis of Eli Lilly and Company
  15.2.4 Eli Lilly and Company Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.3 Allergan
  15.3.1 Company Profile
  15.3.2 Main Business and Neuroprotection Information
  15.3.3 SWOT Analysis of Allergan
  15.3.4 Allergan Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.4 Dr. Reddy’s Laboratories
  15.4.1 Company Profile
  15.4.2 Main Business and Neuroprotection Information
  15.4.3 SWOT Analysis of Dr. Reddy’s Laboratories
  15.4.4 Dr. Reddy’s Laboratories Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.5 Teva Pharmaceutical
  15.5.1 Company Profile
  15.5.2 Main Business and Neuroprotection Information
  15.5.3 SWOT Analysis of Teva Pharmaceutical
  15.5.4 Teva Pharmaceutical Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.6 Novartis
  15.6.1 Company Profile
  15.6.2 Main Business and Neuroprotection Information
  15.6.3 SWOT Analysis of Novartis
  15.6.4 Novartis Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.7 AstraZeneca
  15.7.1 Company Profile
  15.7.2 Main Business and Neuroprotection Information
  15.7.3 SWOT Analysis of AstraZeneca
  15.7.4 AstraZeneca Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
15.8 Astrocyte Pharmaceuticals
  15.8.1 Company Profile
  15.8.2 Main Business and Neuroprotection Information
  15.8.3 SWOT Analysis of Astrocyte Pharmaceuticals
  15.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue, Gross Margin and Market Share (2017-2022)
Please ask for sample pages for full companies list
TABLES AND FIGURES

Table Abbreviation and Acronyms
Table Research Scope of Neuroprotection Report
Table Data Sources of Neuroprotection Report
Table Major Assumptions of Neuroprotection Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Neuroprotection Picture
Table Neuroprotection Classification
Table Neuroprotection Applications
Table Drivers of Neuroprotection Market
Table Restraints of Neuroprotection Market
Table Opportunities of Neuroprotection Market
Table Threats of Neuroprotection Market
Table Covid-19 Impact For Neuroprotection Market
Table Raw Materials Suppliers
Table Different Production Methods of Neuroprotection
Table Cost Structure Analysis of Neuroprotection
Table Key End Users
Table Latest News of Neuroprotection Market
Table Merger and Acquisition
Table Planned/Future Project of Neuroprotection Market
Table Policy of Neuroprotection Market
Table 2017-2027 North America Neuroprotection Market Size
Figure 2017-2027 North America Neuroprotection Market Size and CAGR
Table 2017-2027 North America Neuroprotection Market Size by Application
Table 2017-2022 North America Neuroprotection Key Players Revenue
Table 2017-2022 North America Neuroprotection Key Players Market Share
Table 2017-2027 North America Neuroprotection Market Size by Type
Table 2017-2027 United States Neuroprotection Market Size
Table 2017-2027 Canada Neuroprotection Market Size
Table 2017-2027 Mexico Neuroprotection Market Size
Table 2017-2027 South America Neuroprotection Market Size
Figure 2017-2027 South America Neuroprotection Market Size and CAGR
Table 2017-2027 South America Neuroprotection Market Size by Application
Table 2017-2022 South America Neuroprotection Key Players Revenue
Table 2017-2022 South America Neuroprotection Key Players Market Share
Table 2017-2027 South America Neuroprotection Market Size by Type
Table 2017-2027 Brazil Neuroprotection Market Size
Table 2017-2027 Argentina Neuroprotection Market Size
Table 2017-2027 Chile Neuroprotection Market Size
Table 2017-2027 Peru Neuroprotection Market Size
Table 2017-2027 Asia & Pacific Neuroprotection Market Size
Figure 2017-2027 Asia & Pacific Neuroprotection Market Size and CAGR
Table 2017-2027 Asia & Pacific Neuroprotection Market Size by Application
Table 2017-2022 Asia & Pacific Neuroprotection Key Players Revenue
Table 2017-2022 Asia & Pacific Neuroprotection Key Players Market Share
Table 2017-2027 Asia & Pacific Neuroprotection Market Size by Type
Table 2017-2027 China Neuroprotection Market Size
Table 2017-2027 India Neuroprotection Market Size
Table 2017-2027 Japan Neuroprotection Market Size
Table 2017-2027 South Korea Neuroprotection Market Size
Table 2017-2027 Southeast Asia Neuroprotection Market Size
Table 2017-2027 Australia Neuroprotection Market Size
Table 2017-2027 Europe Neuroprotection Market Size
Figure 2017-2027 Europe Neuroprotection Market Size and CAGR
Table 2017-2027 Europe Neuroprotection Market Size by Application
Table 2017-2022 Europe Neuroprotection Key Players Revenue
Table 2017-2022 Europe Neuroprotection Key Players Market Share
Table 2017-2027 Europe Neuroprotection Market Size by Type
Table 2017-2027 Germany Neuroprotection Market Size
Table 2017-2027 France Neuroprotection Market Size
Table 2017-2027 United Kingdom Neuroprotection Market Size
Table 2017-2027 Italy Neuroprotection Market Size
Table 2017-2027 Spain Neuroprotection Market Size
Table 2017-2027 Belgium Neuroprotection Market Size
Table 2017-2027 Netherlands Neuroprotection Market Size
Table 2017-2027 Austria Neuroprotection Market Size
Table 2017-2027 Poland Neuroprotection Market Size
Table 2017-2027 Russia Neuroprotection Market Size
Table 2017-2027 MEA Neuroprotection Market Size
Figure 2017-2027 MEA Neuroprotection Market Size and CAGR
Table 2017-2027 MEA Neuroprotection Market Size by Application
Table 2017-2022 MEA Neuroprotection Key Players Revenue
Table 2017-2022 MEA Neuroprotection Key Players Market Share
Table 2017-2027 MEA Neuroprotection Market Size by Type
Table 2017-2027 Egypt Neuroprotection Market Size
Table 2017-2027 Israel Neuroprotection Market Size
Table 2017-2027 South Africa Neuroprotection Market Size
Table 2017-2027 Gulf Cooperation Council Countries Neuroprotection Market Size
Table 2017-2027 Turkey Neuroprotection Market Size
Table 2017-2022 Global Neuroprotection Market Size by Region
Table 2017-2022 Global Neuroprotection Market Size Share by Region
Table 2017-2022 Global Neuroprotection Market Size by Application
Table 2017-2022 Global Neuroprotection Market Share by Application
Table 2017-2022 Global Neuroprotection Key Vendors Revenue
Figure 2017-2022 Global Neuroprotection Market Size and Growth Rate
Table 2017-2022 Global Neuroprotection Key Vendors Market Share
Table 2017-2022 Global Neuroprotection Market Size by Type
Table 2017-2022 Global Neuroprotection Market Share by Type
Table 2022-2027 Global Neuroprotection Market Size by Region
Table 2022-2027 Global Neuroprotection Market Size Share by Region
Table 2022-2027 Global Neuroprotection Market Size by Application
Table 2022-2027 Global Neuroprotection Market Share by Application
Table 2022-2027 Global Neuroprotection Key Vendors Revenue
Figure 2022-2027 Global Neuroprotection Market Size and Growth Rate
Table 2022-2027 Global Neuroprotection Key Vendors Market Share
Table 2022-2027 Global Neuroprotection Market Size by Type
Table 2022-2027 Neuroprotection Global Market Share by Type


More Publications